Table of Contents
| Selection of Therapy Method for Stage ? Non Small Cell Lung Cancer after Induction Chemotherapy | PDF HTML |
| Zhendong HU, Jianwei LU, Jun ZHU, Liangjun ZHU, Lin XU | 939-942 |
| Microinvasive Technique for Postoperative Early Bronchial Stump Fistula | PDF HTML |
| Ni ZHANG, Qinzi XU, Xiangning FU | 943-944 |
Perspectives
| Gene Polymorphisms and Chemotherapy in Non-small Cell Lung Cancer | PDF HTML |
| Kayo OSAWA | 837-840 |
Basic Research
| Antiangiogenic Effect of Oyster Polypeptide (OPP) | PDF HTML |
| Zhenhua WANG, Jincheng LIU, Ai SU, Mi SUN, Chunbo WANG | 841-848 |
| The Relationship between the Status of Human Papillomavirus 16/18 Infection and the Expression of Bcl-2 and Bax in Squamous Cell Carcinomas of the Lung | PDF HTML |
| Yi XU, Bin CHENG, Huaxiong PAN, Aijun WU, Li ZHANG | 849-852 |
| The Expression Status of 11 Genes, Located at the Commonly Deleted Region 3p21.3, in Non-small Cell Lung Cancer | PDF HTML |
| Yanhui ZHAI, Ying LI, Wenli HU, Min WEI | 853-858 |
| The Expression and Biological Significance of PD-L1 on Lung Cancer Cell Lines | PDF HTML |
| Cheng CHEN, Chuanyong MU, Qiuxia QU, Yibei ZHU, Jing SUN, Xueguang ZHANG, Jian’an HUANG | 859-863 |
Clinical Research
| Heparanase Expression Correlates with Angiogenesis and Lymphangiogenesis in Human Lung Cancer | PDF HTML |
| Qingfu ZHANG, Jian MING, Yang LI, Siyang ZHANG, Bo LI, Xueshan QIU, Enhua WANG | 864-867 |
| A Meta-analysis of Platinum Plus Taxanes Regimen on Treating Advanced Non-small Cell Lung Cancer | PDF HTML |
| Ning ZHU, Jian HE, Siwei ZHANG, Xiaodong CHEN | 868-874 |
| Expression and Clinical Significance of ABCC10 in the Patients with Non-small Cell Lung Cancer | PDF HTML |
| Peng WANG, Zhipei ZHANG, Kunxiang GAO, Yingchun DENG, Jinbo ZHAO, Boya LIU, Xiaofei LI | 875-878 |
| The Study on Gene Amplification of EGFR in Bronchioloalveolar Carcinoma and Conventional Adenocarcinoma of the Lung | PDF HTML |
| Xin SONG, Zhigang SONG, Yali LV, Mei ZHONG, Xianghong LI | 879-883 |
| Irinotecan/cisplatin versus Etoposide/cisplatin for Patients with Extensive Stage Small Cell Lung Cancer: A Systematic Review | PDF HTML |
| Nan YAO, Lei JIANG, Kehu YANG, Yancheng YE, Denghai MI, Guangtao MIN | 884-888 |
| Clinicopathological Research and Expression of PTEN/PI3K/Akt Signaling Pathway in Non-small Cell Lung Cancer | PDF HTML |
| Hong SHU, HongLan ZHANG, Can XU, Xiaodong ZHAO | 889-892 |
| The Clinical Applications of Combined HBV Approach to Chemotherapy for Non-small Cell Lung Cancer while Adoption of Antivirus Therapy | PDF HTML |
| Lincan DUAN, Gaofeng LI, Yong ZHANG, Lianhuan YE | 893-895 |
Clinical Experience
| Brain Radiotherapy Combined with Sequential Chemotherapy in Non-Small-Cell Lung Cancer Patients with Brain Metastases | PDF HTML |
| Likun CHEN, Qunying YANG, Ying LIANG, Guozhen LIU, Hai LIAO, Guangchuan XU | 896-900 |
| The Pitfall of Transbronchial Lung Biopsy in the Small Cell Carcinoma --Attach 64 Cases Immunohistochemistry Research | PDF HTML |
| Yinping WANG, Limei QU, Yudan HAO | 901-904 |
| Diagnosis and Management of Chylothorax after resection of Lung Cancer | PDF HTML |
| Li WAN, Jianjun WANG, Feng ZHAO, Kai FAN | 905-906 |
Journal Watch
| How epigenetics can explain human metastasis A new role for microRNAs | PDF HTML |
| Amaia Lujambio, Manel Esteller | 907-914 |
| VEGF inhibition and metastasis Possible implications for antiangiogenic therapy | PDF HTML |
| Bevin C. English, Douglas K. Price, William D. Figg | 915-916 |
Minireview
| A Functional Domain Analysis of the BAG Family Proteins and the Relationship with Human Malignancy | PDF HTML |
| Ying LI, Hongyu LIU, Jun CHEN, Qinghua ZHOU | 917-921 |
| The Roles of P120-catenin and the Ttranscriptional Factor Kaiso for the Tumor | PDF HTML |
| Cheng SUN, Yanan LI, Pengxin ZHANG | 922-925 |
| p300/CBP and Lung Cancer | PDF HTML |
| Enwang WANG, Xiaolong YANG | 926-930 |
| Advances of eIF4E Gene and Research in Lung Cancer | PDF HTML |
| Bo ZHANG, Chengchu ZHU | 931-934 |
| Advances in Serum Tumor Markers of Lung Cancer | PDF HTML |
| Hua ZHENG, Wentao YUE, Yunzhong ZHU | 935-938 |
